Print

SciTegic, Inc. Announces Expansion Of Pipeline Pilot Deployment To Six AstraZeneca (AZN) Sites 
10/19/2005 5:10:13 PM

SAN DIEGO--(BUSINESS WIRE)--March 2, 2004--SciTegic® today announced the expansion of Pipeline Pilot(TM) deployment at AstraZeneca from a single site first licensed in 2002, to a global license for multiple sites around the world. AstraZeneca is using Pipeline Pilot in cheminformatics primarily for enumeration of chemical libraries and compound profiling. AstraZeneca has created custom computational protocols tailored to its specific needs. By exposing the newly assembled functions through a standard web browser, they are able to increase the number of users and enhance the impact of computing on drug discovery. "Pipeline Pilot has become increasingly valuable to us in a number of ways. We use it for 'disposable' applications that we can create quickly for one or two people to address any immediate discovery-related issues. In many cases, we've found it to be faster and simpler than writing custom scripts and easier for scientists to understand," said Rich Lawson, Ph.D., global director of IS Strategic Capabilities for Leads within AstraZeneca. "We've also found it very valuable for building more industrial strength applications that our scientists use daily in production at our sites all around the world. The scientific components and the technical framework have proven to be solid, and we've been impressed by the responsiveness and high-quality support of SciTegic staff."

"AstraZeneca has been one of our most collaborative and supportive customers," said Dr. Mathew Hahn, CEO of SciTegic. "Their production use of Pipeline Pilot on a global scale has been a significant driver of the new enterprise capabilities we have built into the forthcoming version 4 of the software."

About SciTegic

SciTegic Inc. is a privately held San Diego company that develops and markets informatics software to the pharmaceutical and biotechnology industries. The company is pioneering a new technology approach called "Data Pipelining" to process drug discovery data with unprecedented flexibility. This new methodology has established its utility by accelerating informatics research for nearly one thousand users at over one hundred customer sites worldwide. Further information about SciTegic is available on the World Wide Web at: www.scitegic.com.

About AstraZeneca (NYSE:AZN - News)

AstraZeneca is a major international pharmaceutical company engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with sales of over US$18.8 billion and leading positions in sales of gastrointestinal, oncology, anaesthesia (including pain management), cardiovascular, neuroscience and respiratory products. Skilled research is at the heart of AstraZeneca's continuing success with over 11,000 R&D employees worldwide and an annual investment of more than $3.1 billion dedicated to the discovery and development of new and improved medicines. For more information about AstraZeneca, visit www.astrazeneca.com.

Note to Editors: SciTegic is a registered trademark and Pipeline Pilot is a trademark in the United States of SciTegic Inc. All other company and/or product names may be trademarks or registered trademarks of their respective owners in the United States and other countries. All rights reserved.

Contact:

SciTegic Inc., San Diego Marty Kleine, 858-279-8800 ext. 214 mkleine@scitegic.com

Source: SciTegic Inc.


//-->